Preliminary studies of histologic prognosis in cancer of the prostate
Harada, M.; Mostofi, F.K.; Corle, D.K.; Byar, D.P.; Trump, B.F.
Cancer Treatment Reports 61(2): 223-225
1977
ISSN/ISBN: 0361-5960 PMID: 872130 Document Number: 118801
Document emailed within 1 workday
Related Documents
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368Lee, F.; Torp-Pedersen, S.; Soiderer, M.H.; Kumasaka, G.H.; Littrup, P.J.; McHugh, T.A.; Schmitter, S.P.; Chang, T.T.; Meyer-Haass, G.M. 1989: Transrectal ultrasound-guided transperineal biopsy: a histologic and cytologic comparison for the diagnosis of prostate cancer Progress in Clinical and Biological Research 303: 11-17
Termansen, N.B.; Thybo, E. 1970: Prognosis in occult cancer of the prostate Ugeskrift for Laeger 132(45): 2127-2129
Murase, T.; Kuriyama, M.; Maeda, S.; Ando, Y.; Itoh, H.; Watanabe, H. 1996: Prognosis in stage a prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 42(9): 639-643
Capoun, O.; Soukup, V.; Mikulová, V.; Jančíková, M.ét.; Honová, H.; Kološtová, K.ín.; Zima, T.áš; Hanuš, T.áš 2014: Circulating tumor cells and prostate cancer prognosis Casopis Lekaru Ceskych 153(2): 72-77
Colombel, M.; Mallame, W.; Abbou, C.C. 1997: Influence of urological complications on the prognosis of prostate cancer European Urology 31(Suppl): 21-24
Lopez, J.G.; Perrin, P. 1999: Cancer of the prostate. Diagnosis, prognosis, principles of treatment La Revue du Praticien 49(3): 297-301
Akimoto, S.; Masai, M.; Isaka, S.; Shimazaki, J.; Murakami, S.; Igarashi, T. 1990: Prognosis of the patients with prostate cancer clinically confined within the pelvis Hinyokika Kiyo. Acta Urologica Japonica 36(9): 1039-1045
Viollet, G.; Robin, M.; Colombeau, P.; Ciblac, G. 1977: Apropos of diagnosis, prognosis and hormonal treatment of cancer of the prostate Journal d'Urologie et de Nephrologie 83(10-11): 896-900
Helfand, B.T.; Xu, J. 2019: Germline testing for prostate cancer prognosis: implications for active surveillance Canadian Journal of Urology 26(5 Suppl 2: 48-49
Umbas, R.; Isaacs, W.B.; Bringuier, P.P.; Schaafsma, H.E.; Karthaus, H.F.; Oosterhof, G.O.; Debruyne, F.M.; Schalken, J.A. 1994: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer Cancer Research 54(14): 3929-3933
Fu, S.; Xu, H.; Liu, C.; Gu, M.; Wang, Q.; Zhou, J.; Wang, Z. 2017: Role of adiponectin in prostate cancer: a preliminary study Zhonghua Nan Ke Xue 23(11): 975-981
Rodríguez Duarte, C.; Mattout, J.; Moreira, O.; Jiménez, R. 2002: Use of brachytherapy in the treatment of localized prostate cancer. Preliminary report Archivos espanoles de urologia 55(7): 785-791
Hogan, T.F.; Citrin, D.L.; Freeberg, B.L. 1981: A preliminary report of mitotane therapy of advanced renal and prostate cancer Cancer Treatment Reports 65(5-6): 539-540
Zhao, W.; Deng, H.; Jie, P.; Qing, C.; Zhang, X. 2010: Preliminary application of strontium-89 for the treatment of bone metastases from prostate cancer Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(6): 1251-1254
Kvols, L.K.; Eagan, R.T.; Myers, R.P. 1977: Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report Cancer Treatment Reports 61(2): 311-312
Rudoni, M.; Sacchetti, G.M.; Leva, L.; Inglese, E.; Monesi, G.; Minocci, D.; Frea, B. 2002: Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer Tumori 88(3): S16-S17
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24